Australia Markets open in 8 hrs 56 mins

Prescient Therapeutics Limited (PTX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1550+0.0050 (+3.33%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.3050
52-week low 30.1000
50-day moving average 30.1479
200-day moving average 30.2054

Share statistics

Avg vol (3-month) 31.47M
Avg vol (10-day) 32.28M
Shares outstanding 5650.09M
Implied shares outstanding 6N/A
Float 8503.24M
% held by insiders 115.80%
% held by institutions 10.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 302 Dec 2014

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-368.58%

Management effectiveness

Return on assets (ttm)-15.25%
Return on equity (ttm)-24.23%

Income statement

Revenue (ttm)1.38M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)30.00%
Gross profit (ttm)1.19M
EBITDA -5.09M
Net income avi to common (ttm)-4.97M
Diluted EPS (ttm)-0.0070
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.79M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)40.22
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-3.88M
Levered free cash flow (ttm)-2.25M